Older MI Survivors Have High Event Risk Over Long Term
Even after one year, risk of mortality, cardiovascular events remains high
Low Diastolic BP Linked to Subclinical Myocardial Damage
Low DBP linked to myocardial damage, CHD events especially among those with SBP ≥120 mm Hg
Risk of Cardiovascular Events Not Reduced With CPAP Use
CPAP helps patients feel better, but does not appear to cut odds for cardiovascular events
Invasive Interventions Improving Survival in NSTEMI Patients
Improvement in all-cause mortality tied to angiography, PCI, and CABG procedures
CABG Plus Optimal Medical Therapy Best in T2DM and CAD
During long-term follow-up, CABG + OMT linked to reduction in composite of death, MI, stroke
Sacubitril-Valsartan Reasonably Cost-Effective in Heart Failure
Cost of $47,053 per quality-adjusted life-year gained in base-case analysis
Andexanet Bolus, Infusion Cuts Anti-Factor Xa Activity
Findings in patients with acute major bleeding associated with factor Xa inhibitors
Echo-LVMI Ups Risk Prediction for Cardiovascular Disease
Left ventricular mass indexed to body size improves risk prediction for CHD, CVD, heart failure
Ezetimibe Plus Rosuvastatin Bests Rosuvastatin Alone
Combo tx linked to significant reductions in LDL, total cholesterol, triglycerides versus rosuvastatin
Adults With CVD Have Gaps in Secondhand Smoke Knowledge
No adults in study spontaneously identified heart risks related to secondhand smoke exposure
